Investigating genetic counselors' communication with Lynch syndrome patients about cascade testing: Barriers, facilitators, and strategies

被引:0
|
作者
Zhong, Lingzi [1 ,2 ,5 ]
Rodriguez, Yanete [3 ]
Espinel, Whitney [1 ]
Ozanne, Elissa M. [4 ]
Kaphingst, Kimberly A. [1 ,2 ]
机构
[1] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[2] Univ Utah, Dept Commun, Salt Lake City, UT USA
[3] Univ Utah, Dept Human Genet, Grad Program Genet Counseling, Salt Lake City, UT USA
[4] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA
[5] Univ Minnesota Duluth, Dept Commun, Duluth, MN USA
关键词
barriers; cascade testing; communication; counseling techniques; facilitators; family; Lynch syndrome; AT-RISK RELATIVES; COLORECTAL-CANCER; INDIVIDUALS; DUTY;
D O I
10.1002/jgc4.1937
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Cascade testing is an imperative process to engage Lynch syndrome patients' at-risk relatives in early cancer risk reduction interventions. How genetic counselors communicate about cascade testing is crucial to patients' intentions of and actual involvement in family communication. Based on data from 20 interviews with genetic counselors, this qualitative study examined their perceptions of barriers and facilitators of offering cascade testing to at-risk relatives and the specific communication strategies they use to discuss cascade testing with patients. We identified patient-level, genetic counselor-level, and system-level barriers and facilitators of having discussions with Lynch syndrome patients about cascade testing. The qualitative data also revealed four prominent communication strategies that genetic counselors use for such discussions: build rapport, reframe the benefits of family communication, adapt communication, and provide various resources. These findings highlight genetic counselors' needs of practical and structural support to facilitate their communication about cascade testing, especially when patients are hesitant or lack resources or skills to notify at-risk relatives about cascade testing.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Communication about genetic testing with breast and ovarian cancer patients: a scoping review
    Jacobs, Chris
    Patch, Christine
    Michie, Susan
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 (04) : 511 - 524
  • [42] A qualitative analysis of patient- and provider-perceived barriers and facilitators to cascade genetic testing for hereditary breast, ovarian, endometrial and colorectal cancer
    Stock, Elizabeth
    Walsh-Bailey, Callie
    Tuda, Daniela
    Tabak, Rachel
    Hagemann, Andrea
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S213 - S213
  • [43] Uptake of Genetic Testing Among Patients with Cancer At Risk for Lynch Syndrome in the National Health Interview Survey
    Actkins, Ky'Era, V
    Srinivasan, Swetha
    Spees, Lisa P.
    Turbitt, Erin
    Allen, Caitlin G.
    Roberts, Megan C.
    CANCER PREVENTION RESEARCH, 2021, 14 (10) : 927 - 931
  • [44] Relatives from Hereditary Breast and Ovarian Cancer and Lynch Syndrome Families Forgoing Genetic Testing: Findings from the Swiss CASCADE Cohort
    Sarki, Mahesh
    Ming, Chang
    Aceti, Monica
    Fink, Guenther
    Aissaoui, Souria
    Buerki, Nicole
    Graffeo, Rossella
    Heinimann, Karl
    Zufferey, Maria Caiata
    Monnerat, Christian
    Rabaglio, Manuela
    Zuerrer-Haerdi, Ursina
    Chappuis, Pierre O.
    Katapodi, Maria C.
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (10):
  • [45] A mixed methods analysis of patient- and provider-perceived barriers and facilitators to cascade genetic testing for hereditary breast, ovarian, endometrial and colorectal cancer
    Stock, Elizabeth
    Walsh-Bailey, Callie
    Tuda, Daniela
    Tabak, Rachel
    Baumann, Ana
    Hagemann, Andrea
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S228 - S229
  • [46] Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort
    Sarki, Mahesh
    Ming, Chang
    Aissaoui, Souria
    Burki, Nicole
    Caiata-Zufferey, Maria
    Erlanger, Tobias Ephraim
    Graffeo-Galbiati, Rossella
    Heinimann, Karl
    Heinzelmann-Schwarz, Viola
    Monnerat, Christian
    Probst-Hensch, Nicole
    Rabaglio, Manuela
    Zurrer-Hardi, Ursina
    Chappuis, Pierre Olivier
    Katapodi, Maria C.
    CANCERS, 2022, 14 (07)
  • [47] Underdiagnosis of Hereditary Colorectal Cancers Among Medicare Patients: Genetic Testing Criteria for Lynch Syndrome Miss the Mark
    Muller, Charles
    Nielsen, Sarah M.
    Hatchell, Kathryn E.
    Yang, Shan
    Michalski, Scott T.
    Hamlington, Barbara
    Nussbaum, Robert L.
    Esplin, Edward D.
    Kupfer, Sonia S.
    JCO PRECISION ONCOLOGY, 2021, 5 : 1103 - 1111
  • [48] Identification of Individuals at Risk for Lynch Syndrome Using Targeted Evaluations and Genetic Testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer Joint Practice Guideline
    Weissman, Scott M.
    Burt, Randall
    Church, James
    Erdman, Steve
    Hampel, Heather
    Holter, Spring
    Jasperson, Kory
    Kalady, Matt F.
    Haidle, Joy Larsen
    Lynch, Henry T.
    Palaniappan, Selvi
    Wise, Paul E.
    Senter, Leigha
    JOURNAL OF GENETIC COUNSELING, 2012, 21 (04) : 484 - 493
  • [49] Disparities in completion of genetic testing and counseling for Lynch syndrome in high-risk patients diagnosed with endometrial cancer
    Holtzman, Sharonne
    Velasquez, Jessica
    Flatow, Virginia
    Selah, Mona
    Cohen, Samantha
    Hayes, Monica Prasad
    Zeligs, Kristen
    Blank, Stephanie
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S291 - S291
  • [50] Prevalence of Variants of Uncertain Significance in Patients Undergoing Genetic Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
    Chrysafi, Pavlina
    Jani, Chinmay T.
    Lotz, Margaret
    Al Omari, Omar
    Singh, Harpreet
    Stafford, Katherine
    Agarwal, Lipisha
    Rupal, Arashdeep
    Dar, Abdul Qadir
    Dangelo, Abby
    Lam, Prudence
    CANCERS, 2023, 15 (24)